Skip to main content

Hemodynamic evaluation of glucagon in symptomatic heart disease.

Publication ,  Journal Article
Armstrong, PW; Gold, HK; Daggett, WM; Austen, WG; Sanders, CA
Published in: Circulation
July 1971

Duke Scholars

Published In

Circulation

DOI

ISSN

0009-7322

Publication Date

July 1971

Volume

44

Issue

1

Start / End Page

67 / 73

Location

United States

Related Subject Headings

  • Vascular Resistance
  • Stimulation, Chemical
  • Isoproterenol
  • Humans
  • Heart Valve Diseases
  • Heart Rate
  • Heart Failure
  • Heart Diseases
  • Glucagon
  • Dye Dilution Technique
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W., Gold, H. K., Daggett, W. M., Austen, W. G., & Sanders, C. A. (1971). Hemodynamic evaluation of glucagon in symptomatic heart disease. Circulation, 44(1), 67–73. https://doi.org/10.1161/01.cir.44.1.67
Armstrong, P. W., H. K. Gold, W. M. Daggett, W. G. Austen, and C. A. Sanders. “Hemodynamic evaluation of glucagon in symptomatic heart disease.Circulation 44, no. 1 (July 1971): 67–73. https://doi.org/10.1161/01.cir.44.1.67.
Armstrong PW, Gold HK, Daggett WM, Austen WG, Sanders CA. Hemodynamic evaluation of glucagon in symptomatic heart disease. Circulation. 1971 Jul;44(1):67–73.
Armstrong, P. W., et al. “Hemodynamic evaluation of glucagon in symptomatic heart disease.Circulation, vol. 44, no. 1, July 1971, pp. 67–73. Pubmed, doi:10.1161/01.cir.44.1.67.
Armstrong PW, Gold HK, Daggett WM, Austen WG, Sanders CA. Hemodynamic evaluation of glucagon in symptomatic heart disease. Circulation. 1971 Jul;44(1):67–73.

Published In

Circulation

DOI

ISSN

0009-7322

Publication Date

July 1971

Volume

44

Issue

1

Start / End Page

67 / 73

Location

United States

Related Subject Headings

  • Vascular Resistance
  • Stimulation, Chemical
  • Isoproterenol
  • Humans
  • Heart Valve Diseases
  • Heart Rate
  • Heart Failure
  • Heart Diseases
  • Glucagon
  • Dye Dilution Technique